Seminars‎ > ‎2017 Spring Seminar‎ > ‎

2017 Program

45th Annual MABB Spring Seminar


Printer-friendly version


Tuesday April 4, 2017

 

Transfusion Medicine Track

Cell Therapy Track

8:00-9:15 AM

 

Compliance: A Behind-the-Scenes View

Joanne A.  Bordner, MT(ASCP), CHS(ABHI)

Compliance Office, MGH

IQCP Tool Implemented for Performing Quality Control Tests on Cellular Products

Andrea Wilson, MS, MBA

QA/QI Specialist, DFCI

9:15-9:45 AM

Break with Exhibitors

 

9:45-11:00 AM

Blood Bank Computer Validation and Vendor Qualification

Robin F. Nozick, BS, MT(ASCP)

Client Consultant, BC Solutions

Sponsored by BC Solutions

HLA Typing by Next Generation Sequencing (NGS)

Alexander Sheh, PhD

Scientist, ARC HLA Laboratory, Dedham, MA

11:00-12:15 PM

Blood Donor Testing for Zika Virus

Jorge Rios, MD

Medical Director, ARC

Covering the Costs: Budgeting for Cellular Product Manufacturing

Elaine Zive

Associate Business Director, Cell Manipulation Core Facility, DFCI

12:15-1:15 Lunch

1:15-2:30 PM

 

Professional Issues - Roundtable Discussion; Topics TBA

2:30-3:00 PM

Break with Exhibitors/Raffle Drawings

3:00-4:15 PM

 

Massachusetts Hemovigilance Update, 2017

Melissa Cumming, M.S.

Anthony Osinski, MPH

Epidemiologists and Hemovigilance Coordinators for Bureau of Infectious Disease and Laboratory Science, MDPH

I Like to Move It, Move It: Challenges to Moving Your Laboratory

Matthew J. Wilgo

Cell Biology Scientist

NE Cord Blood Bank, NE Cryogenic Center, and National Dental Pulp Laboratory

 


Wednesday April 5, 2017

 

Transfusion Medicine Track

Cell Therapy Track

8:00-9:15 AM

 

Case Studies

Emad Balkash, MS, MT(ASCP)SBB

IRL Manager, ARC, Dedham, MA

Neonatal Hypoxic Ischemic Encephalopathy (HIE): An Update on Current Practices and Emerging Therapies

Sara Bates, MD

Attending Neonatologist, MGH

9:15-9:45 AM

Break with Exhibitors

 

9:45-11:00 AM

Tackling Foes Known and Unknown: Pathogen Inactivation Is Here

Gustaaf de Ridder, MD, PhD

Chief Resident in Anatomic and Clinical Pathology, Duke University Medical Center

Sponsored by Cerus Corporation

Autologous Beta Cell Replacement for Diabetes

Albert Hwa, PhD

Operations Director, Center for Cell-Based Therapy

Joslin Diabetes Center

11:00-12:15 PM

Anticoagulation Reversal

Thomas Gage, MD

Medical Director, Hematology Laboratory

Lahey Hospital and Medical Center

 

What Gets Measured Gets Managed: Bone Marrow Harvest Case Study

Bethany King, MS, CQA(ASQ)

Cell Therapy Donor Services Quality and Technical Manager, DFCI

12:15-1:15 Lunch

1:15-2:30 PM

 

Evaluation of Patients with Thrombotic Microangiopathy (TMA)

Katayoun Fayaz M. Fomani, MD

Transfusion Medicine Medical Director, Northwell Health

Sponsored by Alexion Pharmaceuticals


Personalized Tumor Vaccines as a New Paradigm for Cancer Therapy

Jacalyn Rosenblatt, MD

Associate Professor of Medicine and Attending Physician, BIDMC

2:30-3:00 PM

Break with Exhibitors/Raffle Drawings

3:00-4:15 PM

 

RHD Genotyping in Clinical Practice: A Closer Look at Weak D and D variants

Geralyn M. Meny, MD, MS

Physician Consultant, Grifols Diagnostic Solutions

Sponsored by Grifols Diagnostic Solutions

Clonal Hematopoiesis and Adverse Outcomes in Bone Marrow Transplant Patients: Insights From Studies Performed Using Banked Patient Samples

Christopher Gibson, MD

Oncology Fellow, DFCI